GME in Dogs: Neurological Disease Welfare Management
Granulomatous meningoencephalomyelitis (GME) is an immune-mediated inflammatory brain disease causing acute neurological signs, requiring aggressive immunosuppression.
Key Facts
- GME is an immune-mediated disease causing granulomatous inflammation of the central nervous system
- Three forms: focal, multifocal, and ocular, with different clinical presentations
- Small breeds like Poodles and Maltese are predisposed
- Signs include seizures, ataxia, blindness, vestibular signs, and rapid deterioration
- Immunosuppression with corticosteroids and cytarabine can achieve remission in many cases
Welfare Considerations
GME creates acute neurological welfare emergencies through rapid deterioration of brain function. Affected dogs experience seizures, disorientation, loss of coordination, and blindness that are profoundly distressing. Hospitalization and intensive care are required in severe presentations. Immunosuppressive treatment can achieve meaningful remission and allow return to acceptable quality of life, though relapse is common and long-term management is required. Regular neurological reassessment guides treatment and identifies relapse early. The welfare trajectory varies considerably between individuals, making honest prognosis discussions essential.
What You Can Do
- Seek emergency veterinary care immediately for any acute neurological signs
- Work with a veterinary neurologist for diagnosis and treatment planning
- Commit to long-term immunosuppressive management following remission
- Monitor for relapse signs and seek prompt reassessment if they occur
- Discuss quality of life and realistic outcomes openly with your neurologist